FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Lange

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Living Beings

Anatomy

Prostate

Co-author Network

Publications

TOP 3
Paul H Lange
Words of wisdom: re: does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database.
Colm Morrissey; Martine P Roudier; Lawrence D True; Eva Corey; Alex Dowell; Celestia S Higano; Melanie Ketchanji; Paul H Lange; Christopher Welty; Robert L Vessella
Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series.
Christopher J Welty; Jing Xia; Peter S Nelson; Robert L Vessella; Shu Chen; Ilsa Coleman; Roger Coleman; Roman Gulati; Bryce Lakely; Paul H Lange; Sandy R Larson; Bruce Montgomery; Colm Morrissey
Single cell transcriptomic analysis of prostate cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Lange (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Paul H Lange
Words of wisdom: re: does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database.
European urology 2013;63(2):402-3.
2013: Colm Morrissey; Martine P Roudier; Lawrence D True; Eva Corey; Alex Dowell; Celestia S Higano; Melanie Ketchanji; Paul H Lange; Christopher Welty; Robert L Vessella
Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2013;28(2):333-40.
2013: Christopher J Welty; Jing Xia; Peter S Nelson; Robert L Vessella; Shu Chen; Ilsa Coleman; Roger Coleman; Roman Gulati; Bryce Lakely; Paul H Lange; Sandy R Larson; Bruce Montgomery; Colm Morrissey
Single cell transcriptomic analysis of prostate cancer cells.
BMC molecular biology 2013;14():6.
2011: Paul H Lange
Editorial comment.
Urology 2011;78(5):992; author reply 993.
2011: Akash Kumar; Paul H Lange; Choli Lee; Alexandra P MacKenzie; Colm Morrissey; Peter S Nelson; Sarah B Ng; Deborah A Nickerson; Mark J Rieder; Stephen J Salipante; Nigel Clegg; Ilsa Coleman; Eva Corey; Ruth F Dumpit; Robert L Vessella; Thomas A White; Jay Shendure
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(41):17087-92.
2010: Paul H Lange
Words of wisdom. Re: Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer. Morris MJ, Huang D, Kelly WK, et al. Eur Urol 2009;56:237-44.
European urology 2010;58(2):311-2.
2010: Jonathan L Wright; Bruce L Dalkin; Lawrence True; William J Ellis; Janet L Stanford; Paul H Lange; Daniel W Lin
Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.
The Journal of urology 2010;183(6):2213-8.
2009: Zheng (David) Qian; Chung-Ying Huang; Catherine A O'Brien; Ilsa M Coleman; Mark Garzotto; Lawrence True; Celestia S Higano; Robert Vessella; Paul H Lange; Peter S Nelson; Tomasz M Beer
Prostate cancer-associated gene expression alterations determined from needle biopsies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):3135-42.
2009: Paul H Lange
The future of urologic oncology: "Proceduralists" or continued leaders?
Urologic oncology 2009;27(2):118-9.
2009: Paul H Lange
Words of wisdom. Re: Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?
European urology 2009;55(2):524-5.
2008: Hong Gee Sim; Donatello Telesca; Stephen Hembree Culp; William J Ellis; Paul H Lange; Lawrence True; Daniel W Lin
Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.
The Journal of urology 2008;179(5):1775-9.
2008: Colm Morrissey; Lawrence True; Martine P Roudier; Ilsa M Coleman; Sarah Hawley; Peter S Nelson; Roger Coleman; Ya-Chun Wang; Eva Corey; Paul H Lange; Celestia S Higano; Robert L Vessella
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.
Clinical & experimental metastasis 2008;25(4):377-88.
2007: Chung-Ying Huang; Tomasz M Beer; Celestia S Higano; Lawrence True; Robert L Vessella; Paul H Lange; Mark Garzotto; Peter S Nelson
Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5825-33.
2007: William J Ellis; Paul H Lange
Point: open radical prostatectomy should not be abandoned.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):685-8.
2007: Hong Gee Sim; Paul H Lange; Daniel W Lin
Role of post-chemotherapy surgery in germ cell tumors.
The Urologic clinics of North America 2007;34(2):199-217; abstract ix.
2007: Jesco Pfitzenmaier; William J Ellis; Sarah Hawley; Edward W Arfman; Jeffrey R Klein; Paul H Lange; Robert L Vessella
The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
Urologic oncology 2007;25(3):214-20.
2007: Jonathan L Wright; Paul H Lange
Newer potential biomarkers in prostate cancer.
Reviews in urology 2007;9(4):207-13.
2007: Todd M Morgan; Paul H Lange; Robert L Vessella
Detection and characterization of circulating and disseminated prostate cancer cells.
Frontiers in bioscience : a journal and virtual library 2007;12():3000-9.
2007: Paul H Lange
Genitourinary oncology and its surgeon scientists: triumphant past, but does it have a future?
Urologic oncology 2007;25(1):2-10.
2006: Donna L Berry; William J Ellis; Kenneth J Russell; John C Blasko; Nigel Bush; Brent Blumenstein; Paul H Lange
Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer.
Clinical genitourinary cancer 2006;5(3):219-26.
2006: Hong Gee Sim; Michel Kliot; Paul H Lange; William J Ellis; Thomas K Takayama; Claire C Yang
Two-year outcome of unilateral sural nerve interposition graft after radical prostatectomy.
Urology 2006;68(6):1290-4.
2006: Jonathan L Wright; Michael P Porter; Christopher I Li; Paul H Lange; Daniel W Lin
Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
Cancer 2006;107(4):721-8.
2006: Michael P Porter; Janet L Stanford; Paul H Lange
The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.
The Prostate 2006;66(10):1044-51.
2006: Jesco Pfitzenmaier; William J Ellis; Edward W Arfman; Sarah Hawley; Patrick O McLaughlin; Paul H Lange; Robert L Vessella
Telomerase activity in disseminated prostate cancer cells.
BJU international 2006;97(6):1309-13.
2005: Daniel W Lin; Paul H Lange
Editorial comment on "Treatment of nonretroperitoneal residual germ cell tumor masses".
Urologic oncology 2005;23(6):439-40.
2005: Michael P Porter; Paul H Lange
Controversies in the surgical management of renal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(1):95-102.
2005: Peter C Black; Paul H Lange
Cystoprostatectomy and neobladder construction for florid cystitis glandularis.
Urology 2005;65(1):174.
2004: Paul H Lange; Daniel W Lin
Does the who and how of surgery in bladder cancer matter?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2762-4.
2004: Tomasz M Beer; Mark Garzotto; Bruce A Lowe; William J Ellis; Michelle A Montalto; Paul H Lange; Celestia S Higano
Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1306-11.
2003: Peter C Black; Paul H Lange; Thomas K Takayama
Extensive palliative surgery for advanced mesothelioma of the tunica vaginalis.
Urology 2003;62(4):748.
2003: William J Ellis; Jesco Pfitzenmaier; Janet Colli; Edward W Arfman; Paul H Lange; Robert L Vessella
Detection and isolation of prostate cancer cells from peripheral blood and bone marrow.
Urology 2003;61(2):277-81.
2001: J M Brown; Robert L Vessella; Paul J Kostenuik; Colin R Dunstan; Paul H Lange; Eva Corey
Serum osteoprotegerin levels are increased in patients with advanced prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):2977-83.
2001: Sebastian W Melchior; Jennifer L Noteboom; Rolf Gillitzer; Paul H Lange; Brent Blumenstein; Robert L Vessella
The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy.
BJU international 2001;88(3):221-5.
2001: R Thomas; Lawrence True; Paul H Lange; Robert L Vessella
Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: relation to tumor development and progression.
International journal of cancer. Journal international du cancer 2001;93(1):47-52.
2001: Douglas G McNeel; LD Nguyen; William J Ellis; Celestia S Higano; Paul H Lange; Mary L Disis
Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.
The Prostate 2001;47(3):222-9.
2001: Robert L Vessella; D S Wilbur; Kent R Buhler; Paul H Lange
Experimental models and methods in antibody targeting of renal cell carcinoma.
Methods in molecular medicine 2001;53():217-42.
2000: Douglas G McNeel; LD Nguyen; B E Storer; R Vessella; Paul H Lange; Mary L Disis
Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer.
The Journal of urology 2000;164(5):1825-9.
2000: John N Krieger; Donald E Riley; R L Vesella; D C Miner; Susan O Ross; Paul H Lange
Bacterial dna sequences in prostate tissue from patients with prostate cancer and chronic prostatitis.
The Journal of urology 2000;164(4):1221-8.
2000: Daniel W Lin; Richard A Santucci; ME Mayo; Paul H Lange; M E Mitchell
Urodynamic evaluation and long-term results of the orthotopic gastric neobladder in men.
The Journal of urology 2000;164(2):356-9.
2000: Kent R Buhler; Richard A Santucci; R A Royai; S C Whitney; Robert L Vessella; Paul H Lange; William J Ellis
Intermittent androgen suppression in the LuCaP 23.12 prostate cancer xenograft model.
The Prostate 2000;43(1):63-70.
2000: R Thomas; Lawrence True; James A Bassuk; Paul H Lange; Robert L Vessella
Differential expression of osteonectin/SPARC during human prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):1140-9.
1999: Richard A Santucci; C H Park; ME Mayo; Paul H Lange
Continence and urodynamic parameters of continent urinary reservoirs: comparison of gastric, ileal, ileocolic, right colon, and sigmoid segments.
Urology 1999;54(2):252-7.
1999: Alvin Y Liu; Lawrence True; L LaTray; William J Ellis; Robert L Vessella; Paul H Lange; Celestia S Higano; Leroy Hood; Ger van den Engh
Analysis and sorting of prostate cancer cell types by flow cytometry.
The Prostate 1999;40(3):192-9.
1999: Sebastian W Melchior; Lisha G Brown; W D Figg; Janna E Quinn; Richard A Santucci; J Brunner; Joachim W Thüroff; Paul H Lange; Robert L Vessella
Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.
International journal of oncology 1999;14(3):501-8.
1998: Daniel W Lin; Jennifer L Noteboom; Brent Blumenstein; William J Ellis; Paul H Lange; Robert L Vessella
Serum percent free prostate-specific antigen in metastatic prostate cancer.
Urology 1998;52(3):366-71.
1998: William J Ellis; Robert L Vessella; Eva Corey; Edward W Arfman; MM Oswin; Sebastian W Melchior; Paul H Lange
The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer.
The Journal of urology 1998;159(4):1134-8.
1998: Paul H Lange; Robert L Vessella
Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone.
Cancer metastasis reviews 1998;17(4):331-6.
1997: William J Ellis; Robert L Vessella; Jennifer L Noteboom; Paul H Lange; RL Wolfert; Harry G Rittenhouse
Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.
Urology 1997;50(4):573-9.
1997: Alvin Y Liu; Lawrence True; L LaTray; Peter S Nelson; William J Ellis; Robert L Vessella; Paul H Lange; Leroy Hood; Ger van den Engh
Cell-cell interaction in prostate gene regulation and cytodifferentiation.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(20):10705-10.
1997: Eva Corey; S K Wegner; JE Stray; Michael J Corey; Edward W Arfman; Paul H Lange; Robert L Vessella
Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.
International journal of cancer. Journal international du cancer 1997;71(6):1019-28.
1997: Robert L Vessella; Paul H Lange
Issues in the assessment of prostate-specific antigen immunoassays. An update.
The Urologic clinics of North America 1997;24(2):261-8.
1997: Richard A Santucci; Lawrence True; Paul H Lange
Is partial cystectomy the treatment of choice for mucinous adenocarcinoma of the urachus?
Urology 1997;49(4):536-40.
1997: Alvin Y Liu; Eva Corey; Robert L Vessella; Paul H Lange; Lawrence True; G M Huang; Peter S Nelson; Leroy Hood
Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer.
The Prostate 1997;30(3):145-53.
1997: Sebastian W Melchior; Eva Corey; William J Ellis; A A Ross; T J Layton; MM Oswin; Paul H Lange; Robert L Vessella
Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(2):249-56.
1996: C S Higano; William Ellis; Kenneth Russell; Paul H Lange
Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study.
Urology 1996;48(5):800-4.
1996: Franck Bladou; Robert L Vessella; Kent R Buhler; William J Ellis; Lawrence True; Paul H Lange
Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration.
International journal of cancer. Journal international du cancer 1996;67(6):785-90.
1996: William J Ellis; Robert L Vessella; Kent R Buhler; Franck Bladou; Lawrence True; S A Bigler; D Curtis; Paul H Lange
Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(6):1039-48.
1996: A Y Liu; Eva Corey; Franck Bladou; Paul H Lange; Robert L Vessella
Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration.
International journal of cancer. Journal international du cancer 1996;65(1):85-9.
1994: William J Ellis; Paul H Lange
Prostate cancer.
Endocrinology and metabolism clinics of North America 1994;23(4):809-24.
1994: Paul H Lange
Future studies in localized prostate cancer. What should we think? What can we do?
The Journal of urology 1994;152(5 Pt 2):1932-8.
1994: T K Takayama; Paul H Lange
Radiation therapy for local recurrence of prostate cancer after radical prostatectomy.
The Urologic clinics of North America 1994;21(4):687-700.
1994: Christopher L Marsh; Paul H Lange
Application of liver transplant and organ procurement techniques to difficult upper abdominal urological cases.
The Journal of urology 1994;151(6):1652-6.
1994: T K Takayama; Robert L Vessella; Michael K Brawer; Lawrence True; Jennifer L Noteboom; Paul H Lange
Urinary prostate specific antigen levels after radical prostatectomy.
The Journal of urology 1994;151(1):82-7.
1993: Robert L Vessella; Paul H Lange
Issues in the assessment of PSA immunoassays.
The Urologic clinics of North America 1993;20(4):607-19.
1993: T K Takayama; Robert L Vessella; Michael K Brawer; Jennifer L Noteboom; Paul H Lange
The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay.
The Journal of urology 1993;150(2 Pt 1):374-8.
1993: Michael K Brawer; J Beatie; M H Wener; Robert L Vessella; S D Preston; Paul H Lange
Screening for prostatic carcinoma with prostate specific antigen: results of the second year.
The Journal of urology 1993;150(1):106-9.
1992: T K Takayama; John N Krieger; Lawrence True; Paul H Lange
Recurrent prostate cancer despite undetectable prostate specific antigen.
The Journal of urology 1992;148(5):1541-2.
1992: Robert L Vessella; Jennifer L Noteboom; Paul H Lange
Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
Clinical chemistry 1992;38(10):2044-54.
1992: Michael K Brawer; M P Chetner; J Beatie; D M Buchner; Robert L Vessella; Paul H Lange
Screening for prostatic carcinoma with prostate specific antigen.
The Journal of urology 1992;147(3 Pt 2):841-5.
1991: Michael K Brawer; S A Bigler; O E Sohlberg; Raymond B Nagle; Paul H Lange
Significance of prostatic intraepithelial neoplasia on prostate needle biopsy.
Urology 1991;38(2):103-7.
1990: Paul H Lange
Prostatic specific antigen in diagnosis and management of prostate cancer.
Urology 1990;36(5 Suppl):25-9.
1990: Paul H Lange
Prostate-specific antigen for staging prior to surgery and for early detection of recurrence after surgery.
The Urologic clinics of North America 1990;17(4):813-7.
1989: Paul H Lange
Controversies in management of apparently localized carcinoma of prostate.
Urology 1989;34(4 Suppl):13-8; discussion 46-56.
1989: Paul H Lange; Michael K Brawer
Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
Urology 1989;33(6 Suppl):13-7.
1989: Michael K Brawer; Paul H Lange
Prostate-specific antigen in management of prostatic carcinoma.
Urology 1989;33(5 Suppl):11-6.